Plant Comparison
Elecampane vs Lungwort
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Elecampane and Lungwort: they share 6 indicated uses (arthritis / joint pain, bronchitis, cough, …); 2 pharmacological actions in common.
Evidence face-off — shared uses
| Condition | Elecampane | Lungwort | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 2/10 | 2/10 | Comparable evidence |
| Bronchitis | 1/10 | 1/10 | Comparable evidence |
| Cough | 1/10 | 1/10 | Comparable evidence |
| Inflammation (general) | 2/10 | 2/10 | Comparable evidence |
| Respiratory support | 1/10 | 2/10 | Comparable evidence |
| Skin irritation | 2/10 | 1/10 | Comparable evidence |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
The antimicrobial and anti-inflammatory principles of the root; the eudesmane core and the alpha,beta-methylene-lactone ring are essential for the antimicrobial activity.
A fructan polysaccharide abundant in the root (the genus Inula gives inulin its name).
The main antioxidant and COX-2-inhibiting constituents; LC-MS/MS profiling of the aerial parts identified dozens of phenolic compounds (caffeic acid esters and danshensu/dicaffeic-acid conjugates), nine of them previously undescribed, with marked seasonal variation.
Pharmacological Actions
Anti-inflammatory - sesquiterpene lactones (alantolactone, isoalantolactone) inhibit NF-kB and MAPK signalling and pro-inflammatory cytokines; total sesquiterpene lactones eased arthritis in animal models (potential in rheumatoid arthritis)
Antimicrobial, notably anti-staphylococcal (membrane-damaging) and anti-mycobacterial (active against Mycobacterium tuberculosis in vitro); supports respiratory and skin infection
Traditional & Indicated Uses
Anti-inflammatory - sesquiterpene lactones (alantolactone, isoalantolactone) inhibit NF-kB and MAPK signalling and pro-inflammatory cytokines; total sesquiterpene lactones eased arthritis in animal models (potential in rheumatoid arthritis)
Expectorant for productive cough and bronchitis (long-standing respiratory remedy)
inferred from anticancer action
Expectorant for productive cough and bronchitis (long-standing respiratory remedy); Soothes irritated airways / chronic catarrh (traditional)
Antimicrobial, notably anti-staphylococcal (membrane-damaging) and anti-mycobacterial (active against Mycobacterium tuberculosis in vitro); supports respiratory and skin infection
inferred from anti-inflammatory action
inferred from expectorant action
inferred from anti-inflammatory action
inferred from anti-inflammatory action
Traditional demulcent / expectorant for cough, bronchitis, sore throat and respiratory catarrh (mucilage and saponins)
Traditional demulcent / expectorant for cough, bronchitis, sore throat and respiratory catarrh (mucilage and saponins)
inferred from anti-inflammatory action
Traditional demulcent / expectorant for cough, bronchitis, sore throat and respiratory catarrh (mucilage and saponins)
inferred from demulcent action
Traditional demulcent / expectorant for cough, bronchitis, sore throat and respiratory catarrh (mucilage and saponins)
Safety, Cautions & Contraindications
The sesquiterpene lactones (especially alantolactone) are known skin sensitisers and can cause allergic contact dermatitis; people sensitive to the daisy family (Asteraceae) should be cautious.
Large doses can cause nausea, vomiting and diarrhoea; safety in pregnancy and breastfeeding is not established, so avoid medicinal doses.
As a member of the borage family (Boraginaceae), which can contain hepatotoxic pyrrolizidine alkaloids, prolonged or high-dose internal use is best avoided; use in pregnancy and breastfeeding is not recommended.
Traditional use only; clinical evidence in humans is limited, so a cough or respiratory complaint that persists needs medical assessment.
External Ids
Botanical Description
Tall, robust perennial herb with large, coarse, hairy leaves - broadly oval near the base and progressively smaller up the stem - arising from a thick, aromatic rhizome. Large, shaggy, bright yellow daisy-like flower heads with numerous narrow ray florets are borne at the top of stout, branching stems.[12]
Low, hairy perennial herb (Boraginaceae), 15-30 cm tall. Basal leaves are long-stalked, ovate to lance-shaped, often white-spotted - the spotted pattern was historically likened to diseased lung tissue under the medieval Doctrine of Signatures, giving rise to the name 'lungwort' - and covered in bristly hairs. Funnel-shaped flowers open pink and turn blue as they mature, borne in small coiled clusters (cymes).[10]
Habitat
Grows in damp meadows, pastures, roadsides and woodland margins on moist, rich soils; native to Europe and Western Asia and naturalised in North America.[12]
Native to central and southern Europe, growing in damp, shaded woodland, hedgebanks and scrub on humus-rich soils; widely cultivated as a shade garden plant.[10]
Harvesting
The root and rhizome are dug in autumn of the second or later year, when sesquiterpene lactone and inulin content is highest, then cleaned, sliced and dried.[12]
Aerial flowering parts are cut during flowering (spring); the plant can also be gathered later in the growing season, though the phenolic constituent profile is documented to differ measurably between spring and autumn harvests.[11]
Traditional Uses
Elecampane root has a long European tradition, reflected in the old name 'elf dock', as a warming expectorant remedy for productive cough, bronchitis and chronic respiratory catarrh, and topically and internally as an antimicrobial for skin and wound infections.[12]
Lungwort's spotted leaves inspired its traditional use, under the Doctrine of Signatures, as a remedy for lung and respiratory complaints - coughs, bronchitis, catarrh and sore throat - valued for its soothing mucilage and astringent tannins. Modern research confirms antioxidant and anti-inflammatory (COX-2-inhibiting) activity of its phenolic-rich extract, though clinical trial evidence in humans remains limited.[10]
Preparations
References
Lookalikes Review
Dosage
Not documented
Traditional guidance suggests roughly 2-4 g dried herb per cup as an infusion, up to three times daily, for short-term use; avoid prolonged or high-dose internal use given the borage family's potential pyrrolizidine-alkaloid content. Educational reference only, not a prescription.
References & Sources
- Gierlikowska, B., Gierlikowski, W., Bekier, K., Skalicka-Wozniak, K., Czerwinska, M.E. and Kiss, A.K (2019) 'Inula helenium and Grindelia squarrosa as a source of compounds with anti-inflammatory activity in human neutrophils and cultured human respiratory epithelium', Journal of Ethnopharmacology, 249, pp. 112311. doi:10.1016/j.jep.2019.112311 Preclinical
https://doi.org/10.1016/j.jep.2019.112311 - Gao, S. and Wang, Q. and Tian, X.H. and Li, H.L. and Shen, Y.H. and Xu, X.K. and Wu, G.Z. and Hu, Z.L. and Zhang, W.D (2016) 'Total sesquiterpene lactones prepared from Inula helenium L. has potentials in prevention and therapy of rheumatoid arthritis', Journal of Ethnopharmacology, pp. 39--46. doi:10.1016/j.jep.2016.12.020 Preclinical
https://doi.org/10.1016/j.jep.2016.12.020 - Wang, Q., Gao, S., Wu, G., Yang, N., Zu, X., Li, W., Xie, N., Zhang, R., Li, C., Hu, Z. and Zhang, W (2018) 'Total sesquiterpene lactones isolated from Inula helenium L. attenuates 2,4-dinitrochlorobenzene-induced atopic dermatitis-like skin lesions in mice', Phytomedicine, 46, pp. 78-84. doi:10.1016/j.phymed.2018.04.036 Preclinical
https://doi.org/10.1016/j.phymed.2018.04.036 - Dao, T.T.P., Song, K., Kim, J.Y. and Kim, Y.S (2020) 'Igalan from Inula helenium (L.) suppresses the atopic dermatitis-like response in stimulated HaCaT keratinocytes via JAK/STAT3 signaling', Inflammation Research, 69(3), pp. 309-319. doi:10.1007/s00011-020-01322-4 Preclinical
https://doi.org/10.1007/s00011-020-01322-4 - He, X., Zhao, W., Shao, B., Zhang, B., Liu, T., Sun, C., Huang, H., Wu, J., Liang, J. and Ma, X (2020) 'Natural soluble epoxide hydrolase inhibitors from Inula helenium and their interactions with soluble epoxide hydrolase', International Journal of Biological Macromolecules, 161, pp. 1465-1474. doi:10.1016/j.ijbiomac.2020.04.227 Preclinical
https://doi.org/10.1016/j.ijbiomac.2020.04.227 - Buza, V., Niculae, M., Hanganu, D., Pall, E., Burtescu, R.F., Olah, N., Matei-Latiu, M., Vlasiuc, I., Iozon, I., Szakacs, A.R., Ielciu, I. and Stefanut, L.C (2022) 'Biological Activities and Chemical Profile of Gentiana asclepiadea and Inula helenium Ethanolic Extracts', Molecules, 27(11), pp. 3560. doi:10.3390/molecules27113560 Preclinical
https://doi.org/10.3390/molecules27113560 - Zheng, X., Wu, Z., Xu, J., Zhang, X., Tu, Y., Lei, J., Yuan, R., Cheng, H., Wang, Q. and Yu, J (2021) 'Bioactive sesquiterpenes from Inula helenium', Bioorganic Chemistry, 114, pp. 105066. doi:10.1016/j.bioorg.2021.105066 Preclinical
https://doi.org/10.1016/j.bioorg.2021.105066 - Nder, A.E (2021) 'Efficacy of methanol-water extract of Inula helenium root against oxidative DNA damage', Journal of Traditional Chinese Medicine, 41(2), pp. 293-300. Preclinical
https://scholar.google.com/scholar?q=Efficacy%20of%20methanol-water%20extract%20of%20Inula%20helenium%20root%20against%20oxidative%20DNA%20damage - Chun, J., Song, K. and Kim, Y.S (2018) 'Sesquiterpene lactones-enriched fraction of Inula helenium L. induces apoptosis through inhibition of signal transducers and activators of transcription 3 signaling pathway in MDA-MB-231 breast cancer cells', Phytotherapy Research, 32(12), pp. 2501-2509. doi:10.1002/ptr.6189 Preclinical
https://doi.org/10.1002/ptr.6189 - Li, Y., Ni, Z., Zhu, M., Dong, M., Wang, S., Shi, Q., Zhang, M., Wang, Y., Huo, C., Kiyota, H. and Cong, B (2012) 'Antitumour activities of sesquiterpene lactones from Inula helenium and Inula japonica', Zeitschrift fur Naturforschung C, 67(7-8), pp. 375-380. doi:10.1515/znc-2012-7-804 Preclinical
https://doi.org/10.1515/znc-2012-7-804 - Yan, Y.Y., Zhang, Q., Zhang, B., Yang, B. and Lin, N.M (2019) 'Active ingredients of Inula helenium L. exhibits similar anti-cancer effects as isoalantolactone in pancreatic cancer cells', Natural Product Research, 34(17), pp. 2539-2544. doi:10.1080/14786419.2018.1543676 Preclinical
https://doi.org/10.1080/14786419.2018.1543676 - Kenny, C.R., Stojakowska, A., Furey, A. and Lucey, B (2022) 'From Monographs to Chromatograms: The Antimicrobial Potential of Inula helenium L. (Elecampane) Naturalised in Ireland', Molecules. doi:10.3390/molecules27041406 Traditional / reference
https://doi.org/10.3390/molecules27041406 - Stojanovic-Radic, Z. and Comic, Lj. and Radulovic, N. and Blagojevic, P. and Denic, M. and Miltojevic, A. and Rajkovic, J. and Mihajilov-Krstev, T (2012) 'Antistaphylococcal activity of Inula helenium L. root essential oil: eudesmane sesquiterpene lactones induce cell membrane damage', European Journal of Clinical Microbiology & Infectious Diseases, 31(6), pp. 1015--1025. doi:10.1007/s10096-011-1400-1 Preclinical
https://doi.org/10.1007/s10096-011-1400-1 - Cantrell, C.L. and Abate, L. and Fronczek, F.R. and Franzblau, S.G. and Quijano, L. and Fischer, N.H (1999) 'Antimycobacterial eudesmanolides from Inula helenium and Rudbeckia subtomentosa', Planta Medica, 65(4), pp. 351--355. doi:10.1055/s-1999-14001 Preclinical
https://doi.org/10.1055/s-1999-14001
- Ignjatijevic, A., Andjic, T., Ljesevic, M., Nikolic, B. and others (2025) 'Assessment of Antioxidant Activity and Dose-Dependent Effect on Genotoxicity/Antigenotoxicity of Pulmonaria officinalis Ethanolic Extract', Pharmaceutics, 17(9), pp. 1134. doi:10.3390/pharmaceutics17091134 Preclinical
https://doi.org/10.3390/pharmaceutics17091134 - Krzaczek, T. and others (1995) 'Flavonoid glycosides from aerial parts of Pulmonaria officinalis', Planta Medica, 61(5), pp. 488. doi:10.1055/s-2006-959385 Preclinical
https://doi.org/10.1055/s-2006-959385 - Krzyzanowska-Kowalczyk, J. and others (2019) 'Pulmonaria officinalis L. Extract in Cystic Fibrosis: In Vitro Evidence on Staphylococcus aureus Clinical Isolates', Molecules, 24(6), pp. 1151. doi:10.3390/molecules24061151 Preclinical
https://doi.org/10.3390/molecules24061151 - Neagu, E., Radu, G.L., Albu, C. and Paun, G (2016) 'Antioxidant activity, acetylcholinesterase and tyrosinase inhibitory potential of Pulmonaria officinalis and Centaurium umbellatum extracts', Saudi Journal of Biological Sciences, 25(3), pp. 578-585. doi:10.1016/j.sjbs.2016.02.016 Preclinical
https://doi.org/10.1016/j.sjbs.2016.02.016 - Akram, M. and Rashid, A (2017) 'Anti-coagulant activity of plants: mini review', Journal of Thrombosis and Thrombolysis, 44(3), pp. 406-411. doi:10.1007/s11239-017-1546-5 Meta-analysis / review
https://doi.org/10.1007/s11239-017-1546-5 - Byshevskii, A.Sh., Gerbert, I.Ia., Dement'eva, I.A., Leven, P.I. and Chiriat'ev, E.A (1990) 'Nature, properties and the mechanism of the effect on blood coagulation of the preparation obtained from Pulmonaria officinalis', Gematologiia i Transfuziologiia, 35(10), pp. 6-9. Preclinical
https://scholar.google.com/scholar?q=Nature%2C%20properties%20and%20the%20mechanism%20of%20the%20effect%20on%20blood%20coagulation%20of%20the%20preparation%20obtained%20from%20Pulmonaria%20officinalis - Ivanova, D., Gerova, D., Chervenkov, T. and Yankova, T (2005) 'Polyphenols and antioxidant capacity of Bulgarian medicinal plants', Journal of Ethnopharmacology, 96(1-2), pp. 145-150. doi:10.1016/j.jep.2004.08.033 Preclinical
https://doi.org/10.1016/j.jep.2004.08.033 - Neuhauser, C., Schwarzinger, B., Schwarzinger, C., Feichtinger, M. and others (2024) 'Insulin-Mimetic Activity of Herbal Extracts Identified with Large-Scale Total Internal Reflection Fluorescence Microscopy', Nutrients, 16(14), pp. 2182. doi:10.3390/nu16142182 Preclinical
https://doi.org/10.3390/nu16142182 - Luthy, J., Brauchli, J., Zweifel, U., Schmid, P. and Schlatter, C (1984) 'Pyrrolizidine alkaloids in medicinal plants of Boraginaceae: Borago officinalis L. and Pulmonaria officinalis L', Pharmaceutica Acta Helvetiae, 59(9-10), pp. 242-246. Preclinical
https://scholar.google.com/scholar?q=Pyrrolizidine%20alkaloids%20in%20medicinal%20plants%20of%20Boraginaceae%3A%20Borago%20officinalis%20L.%20and%20Pulmonaria%20officinalis%20L. - Krzyzanowska-Kowalczyk, J., Kowalczyk, M., Ponczek, M.B., Pecio, L., Nowak, P. and Kolodziejczyk-Czepas, J (2021) 'Pulmonaria officinalis and Pulmonaria obscura Extracts as Mitigators of Peroxynitrite-Induced Oxidative Stress and Cyclooxygenase-2 Inhibitors - In Vitro and In Silico Studies', Molecules. doi:10.3390/molecules26030631 Traditional / reference
https://doi.org/10.3390/molecules26030631 - Krzyzanowska-Kowalczyk, J. and Pecio, L. and Moldoch, J. and Ludwiczuk, A. and Kowalczyk, M (2018) 'Novel Phenolic Constituents of Pulmonaria officinalis L. LC-MS/MS Comparison of Spring and Autumn Metabolite Profiles', Molecules, 23(9). doi:10.3390/molecules23092277 Traditional / reference
https://doi.org/10.3390/molecules23092277 - Krzyzanowska-Kowalczyk, J., Kolodziejczyk-Czepas, J., Kowalczyk, M., Pecio, L., Nowak, P. and Stochmal, A (2017) 'Yunnaneic Acid B, a Component of Pulmonaria officinalis Extract, Prevents Peroxynitrite-Induced Oxidative Stress in Vitro', Journal of Agricultural and Food Chemistry, 65(19), pp. 3827--3834. doi:10.1021/acs.jafc.7b00718 Preclinical
https://doi.org/10.1021/acs.jafc.7b00718
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.